140 related articles for article (PubMed ID: 9537833)
1. Role of astrocyte-derived tissue-type plasminogen activator in the regulation of endotoxin-stimulated nitric oxide production by microglial cells.
Vincent VA; Löwik CW; Verheijen JH; de Bart AC; Tilders FJ; Van Dam AM
Glia; 1998 Feb; 22(2):130-7. PubMed ID: 9537833
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
3. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta.
Vincent VA; Tilders FJ; Van Dam AM
Glia; 1997 Mar; 19(3):190-8. PubMed ID: 9063726
[TBL] [Abstract][Full Text] [Related]
5. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK
Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia-enriched or astrocyte-enriched cultures.
Kong LY; McMillian MK; Maronpot R; Hong JS
Brain Res; 1996 Aug; 729(1):102-9. PubMed ID: 8874881
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes modulate nitric oxide production by microglial cells through secretion of serine and glycine.
Yang L; Tanaka J; Zhang B; Sakanaka M; Maeda N
Biochem Biophys Res Commun; 1998 Oct; 251(1):277-82. PubMed ID: 9790946
[TBL] [Abstract][Full Text] [Related]
9. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
10. Astrocytes enhance lipopolysaccharide-induced nitric oxide production by microglial cells.
Solà C; Casal C; Tusell JM; Serratosa J
Eur J Neurosci; 2002 Oct; 16(7):1275-83. PubMed ID: 12405988
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
12. Life imaging of peroxynitrite in rat microglial and astroglial cells: Role of superoxide and antioxidants.
Possel H; Noack H; Keilhoff G; Wolf G
Glia; 2002 Jun; 38(4):339-50. PubMed ID: 12007146
[TBL] [Abstract][Full Text] [Related]
13. Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells.
Wilson HM; Reid FJ; Brown PA; Power DA; Haites NE; Booth NA
Exp Nephrol; 1993; 1(6):343-50. PubMed ID: 8081986
[TBL] [Abstract][Full Text] [Related]
14. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
McGowen R; Biliran H; Sager R; Sheng S
Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
[TBL] [Abstract][Full Text] [Related]
15. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
[TBL] [Abstract][Full Text] [Related]
16. Enhanced release of plasminogen activator inhibitor(s) but not of plasminogen activators by cultured rat glial cells treated with interleukin-1.
Rogister B; Leprince P; Delree P; Van Damme J; Billiau A; Moonen G
Glia; 1990; 3(4):252-7. PubMed ID: 2168862
[TBL] [Abstract][Full Text] [Related]
17. Urokinase-type plasminogen activator regulates cranial neural crest cell migration in vitro.
Agrawal M; Brauer PR
Dev Dyn; 1996 Nov; 207(3):281-90. PubMed ID: 8922527
[TBL] [Abstract][Full Text] [Related]
18. Elimination of hydrocortisone from the medium enables tissue plasminogen activator gene expression by normal and immortalized nonmalignant human epithelial cells.
Myöhänen H; Virtanen I; Vaheri A
Biol Chem; 2001 Nov; 382(11):1563-73. PubMed ID: 11767946
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia.
Liuzzi GM; Mastroianni CM; Latronico T; Mengoni F; Fasano A; Lichtner M; Vullo V; Riccio P
Brain; 2004 Feb; 127(Pt 2):398-407. PubMed ID: 14662518
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
